3Sagerman R H, Tretter P, Ellsworth R M. The treatment of orbit rhadomyosarcoma of children with primary radia- tion therapy [ J ]. Am J Roentgenol Radium Ther Nucl Med, 1972,114(1) :31 -34.
4Maurer H M, Beltangady M, Gehan E A, et al. The In- tergroup Rhabdomyosarcoma Study - I: a final report [J]. Cancer, 1988, 61(2) :209 -220.
5Koscielnak E, Jurgens H, Winkler K, et al. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German cooperative soft tissue sarcoma study [ J ]. Cancer, 1992, 70 (10) : 2557 - 2567.
6Rousseau P, Flamant F, Quintana E, et al. Primary chem- otherapy in rhabdomyosarcoma and other malignant mesen- chymal tumours of the orbit: Results of the International Society of Paediatric Oncology MMT 84 Study [ J ]. J Clin Oncol, 1994,12(3) :516 -521.
7Oberlin O, Rey A, Anderson J, et al. Treatment of or- bital rhabdomyosarcoma: Survival and late effects of treatment--Resuks of an international workshop [ J ]. J Clin Oncol, 2001,19 ( 1 ) : 197 - 204.
8Heyn R, Ragab A, Raney R B, et al. Late effects of therapy in orbital rhabdomyosarcoma in children: A re- port from the Intergroup Rbabdomyosarcoma Study [ J ]. Cancer, 1986,57 (9) : 1738 - 1743.
9Hein P A, Gladstone D J, Bellerive M R, et al. Impor- tance of protocol target definition on the ability to spare normal tissue: An IMRT and 3D - CRT planning com- parison for intraorbital tumors [ J ]. Int J Radiat Oncol Bi- ol Phys,2005,62(5) : 1540 - 1548.
10Raney R B, Maurer H M, Anderson J R, et al. The In- tergroup Rhabdomyosarcoma Study Group (IRSG) : ma- jor lessons from the IRS - I through IRS - IV studies as background for the current IRS - V treatment protocols [J]. Sarcoma, 2001,5(1) :9 - 15.
